Provided by Tiger Trade Technology Pte. Ltd.

Corcept Therapeutics

33.87
-0.1700-0.50%
Post-market: 33.21-0.6600-1.95%17:51 EST
Volume:1.23M
Turnover:41.47M
Market Cap:3.60B
PE:41.30
High:34.18
Open:33.26
Low:32.99
Close:34.04
52wk High:117.33
52wk Low:28.66
Shares:106.37M
Float Shares:86.88M
Volume Ratio:0.97
T/O Rate:1.42%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.8200
EPS(LYR):0.8200
ROE:15.01%
ROA:3.34%
PB:5.56
PE(LYR):41.30

Loading ...

Sep 20, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 19, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 05, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 01, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 01, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 15, 2023

Correspondence

Form CORRESP - Correspondence
Aug 14, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 14, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 07, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 07, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 02, 2023

Major Issues Report

Form 8-K - Current report
Aug 02, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 06, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 25, 2023

Major Issues Report

Form 8-K - Current report
May 09, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
May 03, 2023

Major Issues Report

8-K - Current report
May 03, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Feb 28, 2023

Major Issues Report

8-K - Current report
Feb 28, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 15, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals